Company Profile
Updated: 13-NOV-09Sanofi Aventis S.A.
Non-Quoted Public Company
Edif Torre Diagonal, C/ Josep Pla 2, Barcelona, E-08019, Spain
()34 93 485 94 00, 34 93 485 95 00 fax, http://www.sanofi-aventis.es
Primary SIC: In Vitro & In Vivo Diagnostic Agents, Primary NAICS: In-Vitro Diagnostic Substance Manufacturing
Description: Manufacturing: Manufacture of pharmaceutical preparations in a core group of 4 therapeutic areas: cardiovascular disease/thrombosis; disorders of the central nervous system; internal medicine; oncology; the Group also markets consumer health (OTC) products and generics
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care than National Average.
Heart Disease Weekly; 11/22/2009; 1423 words; ...of helping Texas employers play an active and enthusiastic role in promoting cost-effective delivery of quality health care to the benefit of the community. The report was produced with assistance from sanofi-aventis U.S. About the Dall
Sanofi Pasteur Presents Safety Data on Menactra Vaccine Given to Infants at Infectious Disease Society Meeting.
Pediatrics Week; 11/21/2009; 867 words; ...vaccines division of sanofi-aventis Group (EURONEXT: SAN and...said Miriam Pina, M.D., Sanofi Pasteur's clinical director who presented...Pharmaceutical Company, Sanofi Pasteur, Sanofi-Aventis, Vaccines. This article...
CHI Gathers Biomedical Community for the California Healthcare Policy Forum.
Blood Weekly; 11/19/2009; 982 words; ...biotechnology. California's biomedical community is made...tomorrow," said Martin, CHI's chairman. CHI thanks its...Sciences, Gold sponsors: Sanofi-Aventis and Genentech, Silver sponsor...research organizations. CHI's mission is to advance responsible...
NovaDel Receives Notice of Allowance for New U.S. Patent Covering its Oral Spray Drug Delivery Technology.
Biotech Week; 11/18/2009; 1307 words; ...granted nine patents in the U.S., three patents in Canada...prepared to get a full night's sleep (7-8 hours). Patients...a registered trademark of sanofi-aventis. ABOUT NOVADEL PHARMA NovaDel...marketed drugs. The Company's proprietary technology offers...
CombinatoRx Reports Financial Results for the Third Quarter 2009.(Financial report)
Biotech Week; 11/18/2009; 1615 words; ...its REMS program, Sanofi-Aventis' acquisition of...and Neuromed's proven drug development...approval by the U.S. Food and Drug Administration...2009, the FDA's Anesthetics and Life...as a key asset by Sanofi-Aventis in its pending acquisition...
Recent News Articles
- Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration.
Biotech Week - November 25, 2009 - Zacks Analyst Blog Highlights: Pozen, Sanofi-Aventis, Bristol-Myers, AstraZeneca and ADC Telecommunications Inc.
Business Wire - November 23, 2009 - New GoMeals(TM) iPhone Application from sanofi-aventis U.S. to Help People with Diabetes Eat Healthy Anywhere, Anytime.
PR Newswire - November 19, 2009 - Prasco Enters into Agreements with sanofi-aventis U.S. to Provide Sales Support and Distribution Services for Authorized Generic Versions Under the Winthrop Label in U.S.
Biotech Week - November 18, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
%20products%20and%20generics%20in%20vitro%20&%20in%20vivo%20diagnostic%20agents%20in-vitro%20diagnostic%20substance%20manufacturing%20%20&custom5=%20%20&position=1)